NCT04664634

Brief Summary

The purpose of this study is the development and early-stage validation of a wearable sensor for dysphagia in patients with PD.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Apr 2025

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 6, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 11, 2020

Completed
4.3 years until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2026

Completed
Last Updated

July 15, 2025

Status Verified

July 1, 2025

Enrollment Period

1.2 years

First QC Date

December 6, 2020

Last Update Submit

July 10, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Percent agreement with Gold Standard

    Percent agreement between experimental sensor Gold standard (GS) respiratory inductance plethysmography (RIP) with Inductotrace System®, Ambulatory Monitoring)

    1 year

  • Change in mean swallow frequency during haptic cueing week

    This outcome measures the change in the average number of swallows per hour during the intervention week (Week 2, with haptic cueing) compared to baseline (Week 1, no cueing). Swallows will be manually labeled from sensor audio recordings by at least three independent annotators.

    Week 1 to Week 2

Secondary Outcomes (4)

  • Change in algorithm-detected swallow frequency during haptic cueing week

    Week 1 to Week 2

  • Change in Sialorrhea Clinical Scale for Parkinson's Disease (SCS-PD) score

    Baseline to Week 3

  • Change in ROMP-Swallowing Subscale score

    Baseline to Week 3

  • Change in participant adherence to haptic cueing

    Week 2

Other Outcomes (2)

  • Change in Modified Barium Swallow Impairment Profile (MBSImP)

    Baseline to Week 3

  • Change in Penetration-Aspiration Scale Score

    Baseline to Week 3

Study Arms (1)

Single Arm

EXPERIMENTAL

The Aria sensor is a wearable patch that continuously monitors physiological signals and provides vibratory haptic cues to increase swallow frequency. The intervention consists of using the sensor over a 3-week period, with active haptic cueing during Week 2 only.

Device: Aria Sensor

Interventions

The Aria sensor is a wearable patch that continuously monitors physiological signals and provides vibratory haptic cues to increase swallow frequency. The intervention consists of using the sensor over a 3-week period, with active haptic cueing during Week 2 only.

Single Arm

Eligibility Criteria

Age22 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Mild to moderate sialorrhea defined as a score of ≥ 11\* on the Radboud Oral Motor Inventory for Parkinson's Disease (ROMP)-Saliva (C) subscale Subjects must be in the "on" phase of their medication during all study assessments. The "on" phase is defined as the period when the participant's medication is at peak effectiveness, minimizing motor fluctuations and enabling optimal motor function.

You may not qualify if:

  • Known allergy to contrast material used during MBSS. Known allergy to sensor adhesive. Indwelling tracheostomy tube. Nasogastric (NG) feeding tube. Currently pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northwestern University

Evanston, Illinois, 60208, United States

RECRUITING

MeSH Terms

Conditions

Deglutition DisordersParkinson Disease

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic DiseasesParkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 6, 2020

First Posted

December 11, 2020

Study Start

April 1, 2025

Primary Completion

May 31, 2026

Study Completion

May 31, 2026

Last Updated

July 15, 2025

Record last verified: 2025-07

Locations